Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck 2019 Restructuring Program (legacy) by Year
2019 Restructuring Program (legacy) — Recorded in Restructuring Line Item ($M) ($M)
Merck 2019 Restructuring Program (legacy): $471M in FY2023, up 39.8% from a year earlier. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Restructuring Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2019 Restructuring Program (legacy) — Recorded in Restructuring Line Item ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 471 | +39.8% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 337 | -49.0% | Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 661 | – | Form 10-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). Merck 2019 Restructuring Program (legacy) ($M), annual FY2021–FY2023 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr-program2019-line-restr
See every metric in the Merck KPI table. Data updated Oct 26, 2026.